Safety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress Disorder
Public ClinicalTrials.gov record NCT04044664. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Evaluate the Safety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the safety, tolerability, and response profile of NYX-783 in a Post-Traumatic Stress Disorder population.
Study identification
- NCT ID
- NCT04044664
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 25, 2019 (Actual)
- Primary completion
- Aug 5, 2020 (Actual)
- Completion
- Aug 5, 2020 (Actual)
- Last update posted
- May 17, 2022
2019 – 2020
United States locations
- U.S. sites
- 37
- U.S. states
- 19
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aptinyx Clinical Site | Tuscaloosa | Alabama | 35404 | — |
| Aptinyx Clinical Site | Phoenix | Arizona | 85012 | — |
| Aptinyx Clinical Site | Little Rock | Arkansas | 30322 | — |
| Aptinyx Clinical Site | Bellflower | California | 90706 | — |
| Aptinyx Clinical Site | Glendale | California | 91206 | — |
| Aptinyx Clinical Site | Imperial | California | 92251 | — |
| Aptinyx Clinical Site | Oakland | California | 94607 | — |
| Aptinyx Clinical Site | Oceanside | California | 92056 | — |
| Aptinyx Clinical Site | Orange | California | 92868 | — |
| Aptinyx Clinical Site | Riverside | California | 92503 | — |
| Aptinyx Clinical Site | San Diego | California | 92103 | — |
| Aptinyx Clinical Site | San Marcos | California | 92078 | — |
| Aptinyx Clinical Site | Santa Ana | California | 92705 | — |
| Aptinyx Clinical Site | Temecula | California | 32591 | — |
| Aptinyx Clinical Site | Torrance | California | 90502 | — |
| Aptinyx Clinical Site | Colorado Springs | Colorado | 80910 | — |
| Aptinyx Clinical Site | Norwich | Connecticut | 06360 | — |
| Aptinyx Clinical Site | Jacksonville | Florida | 32256 | — |
| Aptinyx Clinical Site | Lauderhill | Florida | 33319 | — |
| Aptinyx Clinical Site | Orlando | Florida | 32801 | — |
| Aptinyx | Atlanta | Georgia | 30329 | — |
| Aptinyx Clinical Site | Atlanta | Georgia | 30331 | — |
| Aptinyx Clinical Site | Hoffman Estates | Illinois | 60619 | — |
| Aptinyx Clinical Site | Boston | Massachusetts | 02131 | — |
| Aptinyx Clinical Site | Las Vegas | Nevada | 89102 | — |
| Aptinyx Clinical Site | Berlin | New Jersey | 08009 | — |
| Aptinyx Clinical Site | Cedarhurst | New York | 11516 | — |
| Aptinyx Clinical Site | New York | New York | 10036 | — |
| Aptinyx Clinical Site | Staten Island | New York | 10312 | — |
| Aptinyx Clinical Site | Salisbury | North Carolina | 28144 | — |
| Aptinyx Clinical Site | Canton | Ohio | 44720 | — |
| Aptinyx Clinical Site | Cincinnati | Ohio | 45219 | — |
| Aptinyx Clinical Site | Oklahoma City | Oklahoma | 73107 | — |
| Aptinyx Clinical Site | Memphis | Tennessee | 38119 | — |
| Aptinyx Clinical Site | Austin | Texas | 78737 | — |
| Aptinyx Clinical Site | San Antonio | Texas | 78229 | — |
| Aptinyx Clinical Site | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04044664, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 17, 2022 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04044664 live on ClinicalTrials.gov.